Heart surgery patients may get kidney protection from old iron drug
NCT ID NCT04633889
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a drug called deferoxamine can prevent acute kidney injury in adults undergoing heart surgery. The drug works by removing excess iron, which is thought to damage the kidneys during surgery. About 320 participants will receive either the drug or a placebo before their operation to see if it reduces kidney complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound-Guided diuretic strategy may boost kidney recovery after cardiac surgery
- A simple urine test and a smart alert may help predict kidney failure in sick kids
- The hidden price tag of kidney injury after heart surgery
- A common amino acid may shield kidneys after heart surgery — a massive analysis puts it to the test
- Urine biomarkers may spot kidney damage before standard tests do
- Urine test after a single dose of furosemide may spot kidney danger in ICU patients